Lv31
370 积分 2025-10-23 加入
Unlocking the mechanisms underlying the activity of pembrolizumab plus enfortumab vedotin in patients with urothelial carcinoma
20天前
已完结
Functional T cells are capable of supernumerary cell division and longevity
1个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
1个月前
已完结
皖公网安备34019202002308
